Correlation of epithelial-mesenchymal transition markers with clinicopathologic parameters in adenocarcinomas and squamous cell carcinoma of the lung

Histology and Histopathology

Volumn 27, Issue 5, 2012, Pages 581-591

  Kim, Seok Hyung ^a   Kim, Jin Man ^b   Shin, Myeong Hee ^c   Kim, Chul Woung ^b   Huang, Song Mei ^b   Kang, Dong Wook ^d   Suh, Kwang Sun ^b   Yi, Eunhee S ^e   Kim, Kyung Hee ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Chungnam National University   (South Korea)

^c Hannam University   (South Korea)

^d Eulji University School of Medicine   (South Korea)

^e MAYO CLINIC   (United States)

Author keywords

Adenocarcinoma; EGFR; Epithelial mesenchymal transition; Non small cell lung carcinoma; Squamous cell carcinoma

Indexed keywords

BETA CATENIN; CADHERIN; CTNNB1 PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; NUCLEAR PROTEIN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TWIST; TWIST1 PROTEIN, HUMAN; VIMENTIN;

ADENOCARCINOMA; AGED; ARTICLE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE DOSAGE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AGED; BETA CATENIN; CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE DOSAGE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NUCLEAR PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSCRIPTION FACTORS; TWIST TRANSCRIPTION FACTOR; VIMENTIN;

GASTROPODA;

EID: 84859350804     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Allred D.C., Harvey J.M., Berardo M. and Clark G.M. (1998). Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod. Pathol. 11, 155-168.
2. Bolos V., Peinado H., Perez-Moreno M.A., Fraga M.F., Esteller M. and Cano A. (2003). The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J. Cell Sci. 116, 499-511.
3. Bremnes R.M., Veve R., Hirsch F.R. and Franklin W.A. (2002). The Ecadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer 36, 115-124.
4. Cappuzzo F., Hirsch F.R., Rossi E., Bartolini S., Ceresoli G.L., Bemis L., Haney J., Witta S., Danenberg K., Domenichini I., Ludovini V., Magrini E., Gregorc V., Doglioni C., Sidoni A., Tonato M., Franklin W.A., Crino L., Bunn P.A Jr. and Varella-Garcia M. (2005). Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer. J. Natl. Cancer Inst. 97, 643-655.
5. Chang T.H., Tsai M.F., Su K.Y., Wu S.G., Huang C.P., Yu S.L., Yu Y.L., Lan C.C., Yang C.H., Lin S.B., Wu C.P., Shih J.Y. and Yang P.C. (2011). Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor. Am. J. Respir. Crit. Care Med. 15, 1071-1079.
6. Deeb G., Wang J., Ramnath N., Slocum H.K., Wiseman S., Beck A. and Tan D. (2004). Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry. Mod. Pathol. 17, 430-439.
7. Deng Q.F., Zhou C.C. and Su C.X. (2009). Clinicopathological features and epidermal growth factor receptor mutations associated with epithelial-mesenchymal transition in non-small cell lung cancer. Respirology 14, 371-376.
8. Gemmill R.M., Roche J., Potiron V.A., Nasarre P., Mitas M., Coldren C.D., Helfrich B.A., Garrett-Mayer E., Bunn P.A. and Drabkin H.A. (2011). ZEB1-responsive genes in non-small cell lung cancer. Cancer Lett. 300, 66-78.
9. Greene F.L., Page D.L., Fleming I.D., Fritz A., Balch C.M., Haller D.G. and Marrow M. (2002). AJCC cancer staging manual, 6th edn. New York, NY. Springer-Verlag.
10. Gupta G.P. and Massague J. (2006). Cancer metastasis: building a framework. Cell 127, 679-695.
11. Hirsch F.R., Varella-Garcia M., Bunn P.A Jr., Di Maria M.V., Veve R., Bremmes R.M., Baron A.E., Zeng C. and Franklin W.A. (2003). Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J. Clin. Oncol. 21, 3798-3807.
12. Hirsch F.R., Varella-Garcia M., McCoy J., West H., Xavier A.C., Gumerlock P., Bunn P.A Jr., Franklin W.A., Crowley J. and Gandara D.R. (2005). Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study. J. Clin. Oncol. 23, 6838-6845.
13. Hugo H., Ackland M.L., Blick T., Lawrence M.G., Clements J.A., Williams E.D. and Thompson E.W. (2007). Epithelial--mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J. Cell Physiol. 213, 374-383.
14. Hung J.J., Yang M.H., Hsu H.S., Hsu W.H., Liu J.S. and Wu K.J. (2009). Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer. Thorax 64, 1082-1089.
15. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C. and Thun M.J. (2006). Cancer statistics. 2006. CA Cancer J. Clin. 56, 106-130.
16. Jeon Y.K., Sung S.W., Chung J.H., Park W.S., Seo J.W., Kim C.W. and Chung D.H. (2006). Clinicopathologic features and prognostic implications of epidermal growth factor receptor (EGFR) gene copy number and protein expression in non-small cell lung cancer. Lung Cancer 54, 387-398.
17. Lee H.J., Xu X.H., Choe G., Chung D.H., Seo J.W., Lee J.H., Lee C.T., Jheon S., Sung S.W. and Chung J.H. (2010). Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study. Lung Cancer 68, 375-382.
18. Leptin M. and Grunewald B. (1990). Cell shape changes during gastrulation in Drosophila. Development 110, 73-84.
19. Li L., Cserjesi P. and Olson E.N. (1995). Dermo-1: a novel twist-related bHLH protein expressed in the developing dermis. Dev. Biol. 172, 280-292.
20. Li L.P., Lu C.H., Chen Z.P., Ge F., Wang T., Wang W., Xiao C.L., Yin X.F., Liu L., He J.X. and He Q.Y. (2011). Subcellular proteomics revealed the epithelial-mesenchymal transition phenotype in lung cancer. Proteomics 11, 429-439.
21. Miura N., Yano T., Shoji F., Kawano D., Takenaka T., Ito K., Morodomi Y., Yoshino I. and Maehara Y. (2009). Clinicopathological significance of Sip1-associated epithelial mesenchymal transition in non-small cell lung cancer progression. Anticancer Res. 29, 4099-4106.
22. Oda H., Tsukita S. and Takeichi M. (1998). Dynamic behavior of the cadherin-based cell-cell adhesion system during Drosophila gastrulation. Dev. Biol. 203, 435-450.
23. Prudkin L., Liu D.D., Ozburn N.C., Sun M., Behrens C., Tang X., Brown K.C., Bekele B.N., Moran C. and Wistuba II. (2009). Epithelial-tomesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung. Mod. Pathol. 22, 668-678.
24. Roy B.C., Kohno T., Iwakawa R., Moriguchi T., Kiyono T., Morishita K., Sanchez-Cespedes M., Akiyama T. and Yokota J. (2010). Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of human lung cancer cells. Lung Cancer 70, 136-145.
25. Sanchez-Garcia I. (2009). The crossroads of oncogenesis and metastasis. N. Engl. J. Med. 360, 297-299.
26. Seki K., Fujimori T., Savagner P., Hata A., Aikawa T., Ogata N., Nabeshima Y. and Kaechoong L. (2003). Mouse Snail family transcription repressors regulate chondrocyte, extracellular matrix, type II collagen, and aggrecan. J. Biol. Chem. 278, 41862-41870.
27. Sharma S.V., Bell D.W., Settleman J. and Haber D.A. (2007). Epidermal growth factor receptor mutations in lung cancer. Nat. Rev. Cancer 7, 169-181.
28. Shia J., Klimstra D.S., Li A.R., Qin J., Saltz L., Teruya-Feldstein J., Akram M., Chung K.Y., Yao D., Paty P.B., Gerald W. and Chen B. (2005). Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study. Mod. Pathol. 18, 1350-1356.
29. Shih J.Y., Tsai M.F., Chang T.H., Chang Y.L., Yuan A., Yu C.J., Lin S.B., Liou G.Y., Lee M.L., Chen J.J., Hong T.M., Yang S.C., Su J.L., Lee Y.C. and Yang P.C. (2005). Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma. Clin. Cancer Res. 11, 8070-8078.
30. Sica G., Yoshizawa A., Sima C.S., Azzoli C.G., Downey R.J., Rusch V.W., Travis W.D. and Moreira A.L. (2010). A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors. Am. J. Surg. Pathol. 34, 1155-1162.
31. Sinicrope F.A., Ruan S.B., Cleary K.R., Stephens L.C., Lee J.J. and Levin B. (1995). bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 55, 237-241.
32. Soltermann A., Tischler V., Arbogast S., Braun J., Probst-Hensch N., Weder W., Moch H. and Kristiansen G. (2008). Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin. Cancer Res. 14, 7430-7437.
33. Thiery J.P. (2002). Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2, 442-454.
34. Thomson S., Buck E., Petti F., Griffin G., Brown E., Ramnarine N., Iwata K.K., Gibson N. and Haley J.D. (2005). Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. Cancer Res. 65, 9455-9462.
35. Witta S.E., Gemmill R.M., Hirsch F.R., Coldren C.D., Hedman K., Ravdel L., Helfrich B., Dziadziuszko R., Chan D.C., Sugita M., Chan Z., Baron A., Franklin W., Drabkin H.A., Girard L., Gazdar A.F., Minna J.D. and Bunn P.A Jr. (2006). Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines. Cancer Res. 66, 944-950.
36. Wolf C., Thisse C., Stoetzel C., Thisse B., Gerlinger P. and Perrin- Schmitt F. (1991). The M-twist gene of Mus is expressed in subsets of mesodermal cells and is closely related to the Xenopus X-twi and the Drosophila twist genes. Dev. Biol. 143, 363-373.
37. Xu J., Lamouille S. and Derynck R. (2009). TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 19, 156-172.
38. Yanagawa J., Walser T.C., Zhu L.X., Hong L., Fishbein M.C., Mah V., Chia D., Goodglick L., Elashoff D.A., Luo J., Magyar C.E.,Dohadwala M., Lee J.M., St John M.A., Strieter R.M., Sharma S. and Dubinett S.M. (2009). Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma. Clin. Cancer Res. 15, 6820-6829.
39. Yang J., Mani S.A., Donaher J.L., Ramaswamy S., Itzykson R.A., Come C., Savagner P., Gitelman I., Richardson A. and Weinberg R.A. (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927-939.
40. Yauch R.L., Januario T., Eberhard D.A., Cavet G., Zhu W., Fu L., Pham T.Q., Soriano R., Stinson J., Seshagiri S., Modrusan Z., Lin C.Y., O'Neill V. and Amler L.C. (2005). Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients. Clin. Cancer Res. 11, 8686-8698.